Closing the vaccine equity gap

Related program: Center for Advocacy and Policy

How PATH is accelerating progress for equitable access to and delivery of lifesaving vaccines

Vaccine equity is crucial for protecting the health and well-being of communities worldwide, ensuring that lifesaving vaccines reach everyone, regardless of their geographic location or socioeconomic status. Despite the availability of vaccines, 21 million children were under-immunized or missing out on immunization entirely in 2023 alone. As barriers to access persist, many children are left at risk of preventable diseases and death.

Advocacy is critical in addressing these inequities by mobilizing political will, securing investments, and holding stakeholders accountable to prioritize equitable vaccine delivery. In partnership with PATH's Center for Vaccine Innovation and Access (CVIA), our teams are at the forefront of this effort, working to develop, deliver, and ensure access to vaccines for women, children, and communities around the globe. Through these efforts, PATH is driving progress toward a healthier, more equitable future.

Highlights from our work:
Center for Vaccine Innovation and Access

PATH's Center for Vaccine Innovation and Access (CVIA) is dedicated to accelerating the development and delivery of lifesaving vaccines for the communities facing the greatest health risks around the world.

Report on the progress towards sustainable financing of immunization in ten African countries

This report explores the status of immunization financing, including the factors affecting adequate financing for immunization, in ten selected African countries.

Financing the future: Securing immunization coverage in Africa

This webinar highlights PATH’s efforts to mobilize funding and drive innovative financing solutions to strengthen immunization systems and ensure sustainable vaccine access across Africa.

Combination vaccines could be the future of immunization programs

This article explores the idea of combination vaccines and how they could be the solution to increasingly unsustainable childhood immunization schedules.